Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.

Two bills that outlined regulations bringing sports gambling to Minnesota were shot down by a state Senate committee on ...

Artificial intelligence is poised to transform healthcare, offering promising advancements in treatment and diagnosis, but experts urge caution regarding privac ...

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

What started as a ‘friendly conversation’ on the UNTHSC campus could lead to a breakthrough in treating glaucoma—the leading ...

Carolyn Adelsten woke up feeling like something was in her eye and it wouldn't come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Re “Next, Chiefs eye history” (Jan. 27): The NFL has a perception problem, and it may be too late to fix it after the Bills-Chiefs game. Going into the game, the Chiefs were already criticized for ...

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...